Kent Emry to Continue as Independent Director Following Planned Leadership Transition ANAHEIM, CA - January 6, 2026 (NEWMEDIAWIRE) - BioCorRx Inc. (OTCID: BICX) (the "Company"), a developer and ...
Mr. Lucido succeeded Kent Emry, who has served on BioCorRx’s Board of Directors since 2013 and will continue to serve as an independent director, ensuring continuity of leadership and governance.
Gordon Scott has been an active investor and technical analyst or 20+ years. He is a Chartered Market Technician (CMT). Thomas J Catalano is a CFP and Registered Investment Adviser with the state of ...
Each and every year, music fans gather to see who will land the coveted Christmas number one spot, earning themselves a spot in the history books. Some of the most iconic festive tracks have soared to ...
Drug delivery describes the method and approach to delivering drugs or pharmaceuticals and other xenobiotics to their site of action within an organism, with the goal of achieving a therapeutic ...
Drug safety relates to the potential for adverse effects related to the administration of drugs. Efforts to establish the safely profile of drugs begin early in their development, with in vitro and in ...
Woman's World on MSN
Which statin is right for you? Compare meds with this handy intensity chart you'll want to save for future reference
If you have high cholesterol, there's a good chance your doctor has recommended statins to get your numbers back into a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback